Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Por um escritor misterioso
Descrição
MBM - Melanoma Brain Metastases
Double Trouble: Immunotherapy Doublets in Melanoma—Approved and Novel Combinations to Optimize Treatment in Advanced Melanoma
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial - The Lancet Oncology
Addition of nivolumab, ipilimumab to chemotherapy extends OS in NSCLC with brain metastases
Cancers, Free Full-Text
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
de
por adulto (o preço varia de acordo com o tamanho do grupo)
